MedPath

Single Dose Study of MK-2214 in Healthy Japanese Participants

Phase 1
Recruiting
Conditions
Alzheimer's Disease
Registration Number
JPRN-jRCT2031220627
Lead Sponsor
Tanaka Yoshiyuki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria

Healthy male or female aged 18 to 75 years old with BMI 18 to 30 kg/m2

Exclusion Criteria

Has a history of clinically significant abnormalities or diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.